Endocrine Abstracts

Introduction: ExFOS is a multinational, non-interventional, prospective, observational study to evaluate fracture outcomes, back pain, compliance and health-related quality of life in osteoporotic patients treated with teriparatide for up to 24 months. We present the baseline characteristics of the Hellenic subpopulation.Methods: In Greece, 439 consenting patients with osteoporosis (92.3% females), suitable for prescribing teriparatide in the course of n...